Network


Latest external collaboration on country level. Dive into details by clicking on the dots.

Hotspot


Dive into the research topics where Nilgun Yaris is active.

Publication


Featured researches published by Nilgun Yaris.


Early Human Development | 2002

The ratio of second- and fourth-digit lengths and congenital adrenal hyperplasia due to 21-hydroxylase deficiency

Ayşenur Ökten; Mukaddes Kalyoncu; Nilgun Yaris

Congenital adrenal hyperplasia (CAH) due to 21-hydroxylase deficiency results in excessive androgen exposure in the gestational period and various degrees of masculinization of the external genitalia in female foetuses. Intrauterine gonadal steroids are not only essential for the development of the genital organs but also affect some other extragenital organ development. The second to fourth digit (2D/4D) ratio shows a sexually dimorphic pattern with longer fourth digit from second digit in men compared to women. A low 2D/4D ratio is associated with high sperm count, testosterone levels and reproductive success in men. A high 2D/4D ratio is associated with high oestrogen levels in women. Second and fourth digit ratio has also found to be correlated with sexual orientation, left hand preference autism and some adult onset diseases such as breast cancer and myocardial infarction. We found lower 2D/4D ratio in female patients with 21-hydroxylase deficiency compared to healthy girls (p=0.000) and equal 2D/4D ratio for female patients when compared to male controls. Male patients with 21-hydroxylase deficiency had significantly lower 2D/4D ratio than female and male controls in the right hand. Healthy boys had lower 2D/4D ratio than healthy girls. It is concluded that 2D/4D ratio established by intrauterine androgen levels influences the sexually dimorphic digit pattern.


Clinical Pediatrics | 2006

Analysis of Children with Peripheral Lymphadenopathy

Nilgun Yaris; Murat Cakir; Emin Sözen; Umit Cobanoglu

In this study, the clinical and laboratory features of children with lymphadenopathy were evaluated. Over a 3-year period, 126 patients were referred to the clinic for lymphadenopathy. Twenty-eight of cases have diseases mimicking lymphadenopathy; 98 (mean age: 86 ± 55 months) have lymphadenopathy. Localized, limited, and generalized involvement was found in 52%, 30%, and 18% of patients. The most common localization was the head and neck region. The causes of lymphadenopathy were benign diseases in 75 patients. Sixty percent were reactive lymphadenopathy, 39% were lymphadenitis. Lymphadenitis was more frequently localized and bigger than 3 cm compared with reactive adenopathy (p = .02, p = .004). Twenty-three patients have malignant diseases whose mean age was higher than others (p = .002). The enlargement of supraclavicular nodes was more likely due to malignant disease (p = .001). The risk of malignant disease was higher in patients who had generalized lymphadenopathy, lymph nodes bigger than 3 cm, hepatosplenomegaly, and high lactate dehydrogenase levels. In conclusion, this study pointed out the important clues for the differential diagnosis, which were present in the history, physical, and laboratory findings.


Pediatric Hematology and Oncology | 2004

Childhood Cancer in Developing Countries

Nilgun Yaris; Aliye Mandiracioglu; Münevver Büyükpamukçu

The problem of childhood cancer cannot be evaluated separately from developmental levels and states of health of the countries. Rapid increase in population, poverty, poor hygiene, lack of education, and multitude health problems impede the development of pediatric oncology and success of the management of childhood cancer in developing countries. More than 85% pediatric cancer cases occur in developing countries that use less than 5% of world resources. The rate will exceed 90% in the next two decades, due to the increase of youth population in favor of developing countries. Incidence rates, pathology, and clinical characteristics of various cancers seem different in developing and developed countries. Different environments, life styles, dietary habits, and hygienic conditions are the main reasons for those differences. Unprecedented changes in diagnostic techniques, treatment methods and supportive care have occurred during the last decades. Consequently, management has improved and the mortality rates have decreased. Most of the children with cancer living in developing countries could not profit from those advances in pediatric oncology because of the cost.


American Journal of Clinical Oncology | 2002

Primary intraspinal primitive neuroectodermal tumor: case report of a tumor arising from the sacral spinal nerve root and review of the literature.

A. Aydin Yavuz; Nilgun Yaris; Melek Nur Yavuz; Ahmet Sari; A. Kadir Reis; Fazil Aydin

Primary spinal primitive neuroectodermal tumor (PNET) is a rare condition, 18 cases of which have been reported in the literature. In general, this tumor is treated with surgery followed by radiotherapy and chemotherapy, but prognosis is still poor. An 18-year-old female patient with an intradural, extramedullary mass at L3–L5 levels is presented in this report. This is the first female patient with primary spinal PNET at lumbar region, second patient with spinal nerve root origin, and third one with intradural, extramedullary localization ever reported in the literature. After surgery, she was treated with craniospinal radiotherapy and four cycles of combination chemotherapy regimen consisting of vincristine, cyclophosphamide, doxorubicin alternated with ifosfamide, and VP-16. Currently, she is asymptomatic and alive at 25 months. The histopathologic, radiologic, and clinical findings of the patient are presented and relevant literature is reviewed.


Pediatric Hematology and Oncology | 2001

MANAGEMENT OF CUTANEOUS HEMANGIOMAS: A RETROSPECTIVE ANALYSIS OF 1109 CASES AND COMPARISON OF CONVENTIONAL DOSE PREDNISOLONE WITH HIGH-DOSE METHYLPREDNISOLONE THERAPY

Canan Akyüz; Nilgun Yaris; M. Tezer Kutluk; Münevver Büyükpamukçu

The effectiveness of the different pharmacological agents and different doses of systemic cortico steroids was analyzed. A total of 1109 patients (median age 8 months; F/M: 2.3) with hemangioma, followed up in our unit for 23 years, were evaluated retrospectively. Forty-five of them received systemic corticosteroids. Two different pharmacological agents, prednisolone (in 26 patients) and methyl prednisolone (in 19 patients), had been used in three different regimens. Groups were compared according to the final results and rebound regrowth. Response was considered good or excellent in 16 patients (36%). There were no differences in response to therapy among the three regimens. No difference was found in response to therapy between prednisolone and methylprednisolone and the two different doses of the methylprednisolone. Rebound regrowth was significantly higher in methyl prednisolone than in the prednisolone group (p = .045). In multivariate analysis the dimension of the lesion (p = .0065) and age at initiation of treatment (p = .0041) were the most important factors affecting the response. In conclusion, the systemic corticosteroids are effective in 36% of patients, independent of dosage and pharmacological agents and duration of the therapy. The dimension of the lesion and age at initiation of treatment are the most important factors affecting the response to treatment.


Pediatric Blood & Cancer | 2006

Thymic carcinoma in children

Nilgun Yaris; Yunus Nas; Umit Cobanoglu; Melek Yavuz

Thymic epithelial neoplasms consist of thymomas, thymic carcinoids, and thymic carcinomas. Carcinomas are malignant tumors of the thymus characterized by obvious cytological anaplasia. They constitute only 4%–14% of thymic epithelial neoplams. Thymic carcinoma rarely occurs in children. Research in the English literature carried out for the present study revealed only 14 cases younger than 18 years‐of‐age. Here we have reported a 16‐year old girl who presented with respiratory distress due to huge anterior mediastinal mass. Histological and immunohistochemical studies confirmed lymphoepithelioma‐like thymic carcinoma. She received systemic chemotherapy and radiotherapy. However, she died within 15 months due to progressive disease.


Annals of Tropical Paediatrics | 2009

Crimean-Congo haemorrhagic fever among children in north-eastern Turkey.

Embiya Dilber; Murat Cakir; E. A. Acar; Fazil Orhan; Nilgun Yaris; Elif Bahat; Ayşenur Ökten; Erol Erduran

Abstract Aim: To analyse the epidemiological and clinical features of children with Crimean–Congo haemorrhagic fever (CCHF) in north-eastern Turkey. Methods: A retrospective study of demographic features and physical and laboratory findings in 21 children with CCHF is described. Clinical course, treatment modalities and outcome were analysed. Results: Most patients were admitted in June and July 2008; most were from the Gumushane and Kelkit valleys and half of them lived in rural areas. Mean (SD) age was 10.3 (3.9) years and the disease was more common in males (71.4%). Approximately 70% had a history of tick bite. The main symptoms were fever (17, 80.9%), nausea (11, 52.3%), malaise (10, 47.6%) and headache (7, 33.3%). At initial examination, approximately 70% of patients had leukopenia and 65% had thrombocytopenia. Anaemia developed during follow-up in six patients. Liver involvement was seen in 12 patients and one patient had acute tubular necrosis. Six patients had haemophagocytosis. Patients were hospitalised for a median 8 days (range 3–22) and nine patients had bleeding from various sites approximately 3–5 days after hospitalisation. Subcutaneous haematoma (6), especially epistaxis and at venepuncture sites (6) were the most common sites of bleeding. Pulmonary haemorrhage developed in two patients and they required ventilatory support. Overall mortality related to CCHF was 4.7% (one patient). Conclusion: Early diagnosis of CCHF and early referral to specialised centres are important for outcome. Exceptional epidemics may be seen in future owing to ecological and environmental changes.


Pediatric Hematology and Oncology | 2010

TREATMENT OF WILMS TUMOR: A Report from the Turkish Pediatric Oncology Group (TPOG)

Canan Akyüz; Bilgehan Yalçın; Inci Yildiz; Volkan Hazar; Asim Yoruk; Gülnur Tokuç; Ferhan Akici; Nebil Büyükpamukçu; Gülsev Kale; Lale Atahan; Cenk Büyükünal; Sergülen Dervişoğlu; Gülyüz Atkovar; Mustafa Melikoglu; Gülten Karpuzoğlu; Nur Olgun; Inci Ayan; Aynur Oguz; Nilgun Yaris; Ayhan Dagdemir; Emin Darendeliler; Serdar Sander; Uğur Kuyumcuoğlu; Naciye Özşeker; Funda Corapcioglu; Atilla Tanyeli; Oznur Duzovali; G. Burça Aydın; Münevver Büyükpamukçu

Aim: To standardize diagnosis and treatment of childhood Wilms tumor (WT) in Turkey. Methods and patients: Between 1998 and 2006, WT patients were registered from 19 centers. Patients <16 years with unilateral WT whose treatment started in first postoperative 3 weeks were included. Treatments were stage I favorable (FH) and unfavorable histology (UH) patients, VCR + Act-D; stage IIA FH, VCR + Act-D; stage IIB FH, VCR + Act-D + radiotherapy (RT); stage III–IV FH, VCR + Act-D + adriamycin (ADR) + RT; stages II–IV UH tumors, VCR + Act-D + ADR + etoposide + RT. Results: 165/254 registered cases were eligible (bilateral, 5.9%) [median age 3.0 years; M/F: 0.99; 50/165 cases ≤2 years]. 9.7% cases had UH tumors. Disease stages were stage I 23.6%; IIA 36.4%; IIB 5.5%; III 22.4%; IV 12.1%. Cases >2 years had significantly more advanced disease. 1/11 cases with recurrent disease died; 2/165 had progressive disease, 2/165 had secondary cancers, and all 4 died. In all cases 4-year OS and EFS were 92.8 and 86.5%, respectively. Both OS and EFS were significantly worse in stage IV. Conclusions: Despite problems in patient management and follow-up, treatment results were encouraging in this first national experience with a multicentric study in pediatric oncology. Revisions and modifications are planned to further improve results and minimize short- and long-term side effects.


Pediatric Hematology and Oncology | 2004

Castleman Disease: A Case with Atypical Presentation

Nilgun Yaris; Murat Cakir; Mukaddes Kalyoncu; Kadriye Yildiz; Ayşenur Ökten

Castleman disease is a benign lymphoproliferative disorder characterized by enlarged lymph nodes. In children the disease is rare, usually localized, and asymptomatic. Resection of the node is almost always curative. A case is reported that was diagnosed as hyaline vascular-type Castleman disease at 1 year of age. The disease recurred from infraclavicular region in addition to primary site, even though total excision was performed. Although the disease is mullticentric after recurrence, the patient has no systemic symptoms.


Leukemia & Lymphoma | 2004

Primary Burkitt's Lymphoma Only Involving the Chest Wall at Relapse in a Child

Nilgun Yaris; Murat Cakir; Ali Ahmetoğlu; Safak Ersoz

Burkitts lymphoma primarily originating from the soft tissue is a very rare neoplasm. A five-year-old boy was admitted with a mass on the lateral side of the right breast. Radiological examination revealed a mass, which had originated from the soft tissue of the chest wall without any contiguous pleural and lung parenchyma disease. Histopathology showed this to be Burkitts lymphoma. To our knowledge, this case is the first instance of Burkitts lymphoma presenting as an isolated chest wall mass which originated from the soft tissue.

Collaboration


Dive into the Nilgun Yaris's collaboration.

Top Co-Authors

Avatar

Ayşenur Ökten

Karadeniz Technical University

View shared research outputs
Top Co-Authors

Avatar

Mukaddes Kalyoncu

Karadeniz Technical University

View shared research outputs
Top Co-Authors

Avatar

Murat Cakir

Karadeniz Technical University

View shared research outputs
Top Co-Authors

Avatar
Top Co-Authors

Avatar

Umit Cobanoglu

Karadeniz Technical University

View shared research outputs
Top Co-Authors

Avatar

Embiya Dilber

Karadeniz Technical University

View shared research outputs
Top Co-Authors

Avatar

Ali Ahmetoğlu

Karadeniz Technical University

View shared research outputs
Top Co-Authors

Avatar

Melek Yavuz

Karadeniz Technical University

View shared research outputs
Top Co-Authors

Avatar

Canan Akyüz

Boston Children's Hospital

View shared research outputs
Top Co-Authors

Avatar

Erol Erduran

Karadeniz Technical University

View shared research outputs
Researchain Logo
Decentralizing Knowledge